Lanthionine ketimine ester provides benefit in a mouse model of multiple sclerosis

Journal of Neurochemistry

Volumn 134, Issue 2, 2015, Pages 302-314

  Dupree, Jeffrey L ^a   Polak, Paul E ^b   Hensley, Kenneth ^c   Pelligrino, Dale ^b   Feinstein, Douglas L ^b,d  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c MEDICAL COLLEGE OF OHIO   (United States)

^d JESSE BROWN VA MEDICAL CENTER   (United States)

Author keywords

axon; collapsin response mediator protein; experimental autoimmune encephalomyelitis; myelin

Indexed keywords

COLLAPSIN RESPONSE MEDIATOR PROTEIN 2; INTERLEUKIN 17; LANTHIONINE KETIMINE ESTER; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; SULFUR AMINO ACID; UNCLASSIFIED DRUG; CYTOKINE; LANTHIONINE KETIMINE; NEUROPROTECTIVE AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ELECTRON MICROSCOPY; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; FEMALE; MOUSE; NERVE DEGENERATION; NEUROPROTECTION; NONHUMAN; OPTIC NERVE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN PHOSPHORYLATION; SPINAL CORD; T LYMPHOCYTE; TH17 CELL; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; DRUG EFFECTS; IMMUNOLOGY; NERVE FIBER; PATHOLOGY; TRANSMISSION ELECTRON MICROSCOPY; WESTERN BLOTTING;

MUS;

AMINO ACIDS, SULFUR; ANIMALS; AXONS; BLOTTING, WESTERN; CYTOKINES; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; MICE; MICE, INBRED C57BL; MICROSCOPY, ELECTRON, TRANSMISSION; NERVE DEGENERATION; NEUROPROTECTIVE AGENTS; OPTIC NERVE; SPINAL CORD; T-LYMPHOCYTES;

EID: 84936744950     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/jnc.13114     Document Type: Article

References (69)

1. Aharoni R., Vainshtein A., Stock A., Eilam R., From R., Shinder V., and, Arnon R., (2011) Distinct pathological patterns in relapsing-remitting and chronic models of experimental autoimmune enchephalomyelitis and the neuroprotective effect of glatiramer acetate. J. Autoimmun. 37, 228-241.
2. Auvergnon N., Reibel S., Touret M., Honnorat J., Baron T., Giraudon P., and, Bencsik A., (2009) Altered expression of CRMPs in the brain of bovine spongiform encephalopathy-infected mice during disease progression. Brain Res. 1261, 1-6.
3. Boullerne A. I., Polak P. E., Braun D., Sharp A., Pelligrino D., and, Feinstein D. L., (2014) Effects of peptide fraction and counter ion on the development of clinical signs in experimental autoimmune encephalomyelitis. J. Neurochem. 129, 696-703.
4. Brown D. A., and, Sawchenko P. E., (2007) Time course and distribution of inflammatory and neurodegenerative events suggest structural bases for the pathogenesis of experimental autoimmune encephalomyelitis. J. Comp. Neurol. 502, 236-260.
5. Campbell G. R., Worrall J. T., and, Mahad D. J., (2014) The central role of mitochondria in axonal degeneration in multiple sclerosis. Mult. Scler. 20, 1806-1813.
6. Cavallini D., Ricci G., Federici G., Costa M., Pensa B., Matarese R. M., and, Achilli M., (1982) The oxidation of sulfur-containing amino acids by L-amino acid oxidases. Adv. Exp. Med. Biol. 148, 359-374.
7. Cavallini D., Ricci G., Dupre S., Pecci L., Costa M., Matarese R. M., Pensa B., Antonucci A., Solinas S. P., and, Fontana M., (1991) Sulfur-containing cyclic ketimines and imino acids. A novel family of endogenous products in the search for a role. Eur. J. Biochem. 202, 217-223.
8. Coetzee T., Fujita N., Dupree J., Shi R., Blight A., Suzuki K., Suzuki K., and, Popko B., (1996) Myelination in the absence of galactocerebroside and sulfatide: normal structure with abnormal function and regional instability. Cell 86, 209-219.
9. Cole A. R., Knebel A., Morrice N. A., Robertson L. A., Irving A. J., Connolly C. N., and, Sutherland C., (2004) GSK-3 phosphorylation of the Alzheimer epitope within collapsin response mediator proteins regulates axon elongation in primary neurons. J. Biol. Chem. 279, 50176-50180.
10. Crawford D. K., Mangiardi M., Song B., Patel R., Du S., Sofroniew M. V., Voskuhl R. R., and, Tiwari-Woodruff S. K., (2010) Oestrogen receptor beta ligand: a novel treatment to enhance endogenous functional remyelination. Brain 133, 2999-3016.
11. Dupre S., Fontana M., Costa M., Pecci L., Ricci G., and, Cavallini D., (1993) Characterization of [35S]lanthionine ketimine specific binding to bovine brain membranes. Biochem. Biophys. Res. Commun. 195, 673-677.
12. Dupree J. L., Coetzee T., Suzuki K., and, Popko B., (1998) Myelin abnormalities in mice deficient in galactocerebroside and sulfatide. J. Neurocytol. 27, 649-659.
13. Dutta R., and, Trapp B. D., (2011) Mechanisms of neuronal dysfunction and degeneration in multiple sclerosis. Prog. Neurobiol. 93, 1-12.
14. Ellwardt E., and, Zipp F., (2014) Molecular mechanisms linking neuroinflammation and neurodegeneration in MS. Exp. Neurol. 262 (Pt A), 8-17.
15. Feinstein D. L., Galea E., Gavrilyuk V., Brosnan C. F., Whitacre C. C., Dumitrescu-Ozimek L., Landreth G. E., Pershadsingh H. A., Weinberg G., and, Heneka M. T., (2002) Peroxisome proliferator-activated receptor-gamma agonists prevent experimental autoimmune encephalomyelitis. Ann. Neurol. 51, 694-702.
16. Fernandez-Gamba A., Leal M. C., Maarouf C. L., Richter-Landsberg C., Wu T., Morelli L., Roher A. E., and, Castano E. M., (2012) Collapsin response mediator protein-2 phosphorylation promotes the reversible retraction of oligodendrocyte processes in response to non-lethal oxidative stress. J. Neurochem. 121, 985-995.
17. Fewou S. N., Ramakrishnan H., Bussow H., Gieselmann V., and, Eckhardt M., (2007) Down-regulation of polysialic acid is required for efficient myelin formation. J. Biol. Chem. 282, 16700-16711.
18. Fontana M., Ricci G., Solinas S. P., Antonucci A., Serao I., Dupre S., and, Cavallini D., (1990) [35S]Lanthionine ketimine binding to bovine brain membranes. Biochem. Biophys. Res. Commun. 171, 480-486.
19. Fontana M., Brunori A., Costa M., and, Antonucci A., (1997) Detection of cystathionine ketimine and lanthionine ketimine in human brain. Neurochem. Res. 22, 821-824.
20. Fressinaud C., Berges R., and, Eyer J., (2012) Axon cytoskeleton proteins specifically modulate oligodendrocyte growth and differentiation in vitro. Neurochem. Int. 60, 78-90.
21. Goshima Y., Nakamura F., Strittmatter P., and, Strittmatter S. M., (1995) Collapsin-induced growth cone collapse mediated by an intracellular protein related to UNC-33. Nature 376, 509-514.
22. Grundke-Iqbal I., Raine C. S., Johnson A. B., Brosnan C. F., and, Bornstein M. B., (1981) Experimental allergic encephalomyelitis. Characterization of serum factors causing demyelination and swelling of myelin. J. Neurol. Sci. 50, 63-79.
23. Guy J., Ellis E. A., Hope G. M., and, Emerson S., (1991) Maintenance of myelinated fibre g ratio in acute experimental allergic encephalomyelitis. Brain 114 (Pt 1A), 281-294.
24. Hensley K., and, Denton T. T., (2014) Alternative functions of the brain transsulfuration pathway represent an underappreciated aspect of brain redox biochemistry with significant potential for therapeutic engagement. Free Radic. Biol. Med. 78C, 123-134.
25. Hensley K., Christov A., Kamat S., Zhang X. C., Jackson K. W., Snow S., and, Post J., (2010a) Proteomic identification of binding partners for the brain metabolite lanthionine ketimine (LK) and documentation of LK effects on microglia and motoneuron cell cultures. J. Neurosci. 30, 2979-2988.
26. Hensley K., Venkova K., and, Christov A., (2010b) Emerging biological importance of central nervous system lanthionines. Molecules 15, 5581-5594.
27. Hensley K., Venkova K., Christov A., Gunning W., and, Park J., (2011) Collapsin response mediator protein-2: an emerging pathologic feature and therapeutic target for neurodisease indications. Mol. Neurobiol. 43, 180-191.
28. Hensley K., Gabbita S. P., Venkova K., Hristov A., Johnson M. F., Eslami P., and, Harris-White M. E., (2013) A derivative of the brain metabolite lanthionine ketimine improves cognition and diminishes pathology in the 3 x Tg-AD mouse model of Alzheimer disease. J. Neuropathol. Exp. Neurol. 72, 955-969.
29. Higurashi M., Iketani M., Takei K., Yamashita N., Aoki R., Kawahara N., and, Goshima Y., (2012) Localized role of CRMP1 and CRMP2 in neurite outgrowth and growth cone steering. Dev. Neurobiol. 72, 1528-1540.
30. Hou S. T., Jiang S. X., Aylsworth A., Ferguson G., Slinn J., Hu H., Leung T., Kappler J., and, Kaibuchi K., (2009) CaMKII phosphorylates collapsin response mediator protein 2 and modulates axonal damage during glutamate excitotoxicity. J. Neurochem. 111, 870-881.
31. Hubbard C., Benda E., Hardin T., Baxter T., St J. E., O'Brien S., Hensley K., and, Holgado A. M., (2013) Lanthionine ketimine ethyl ester partially rescues neurodevelopmental defects in unc-33 (DPYSL2/CRMP2) mutants. J. Neurosci. Res. 91, 1183-1190.
32. Ip J. P., Fu A. K., and, Ip N. Y., (2014) CRMP2: functional roles in neural development and therapeutic potential in neurological diseases. Neuroscientist 20, 589-598.
33. Khanna R., Wilson S. M., Brittain J. M., Weimer J., Sultana R., Butterfield A., and, Hensley K., (2012) Opening Pandora's jar: a primer on the putative roles of CRMP2 in a panoply of neurodegenerative, sensory and motor neuron, and central disorders. Future Neurol. 7, 749-771.
34. Kondo A., Nagara H., Akazawa K., Tateishi J., Serikawa T., and, Yamada J., (1991) CNS pathology in the neurological mutant rats zitter, tremor and zitter-tremor double mutant (spontaneously epileptic rat, SER). Exaggeration of clinical and neuropathological phenotypes in SER. Brain 114 (Pt 2), 979-999.
35. Kuerten S., Gruppe T. L., Laurentius L. M., Kirch C., Tary-Lehmann M., Lehmann P. V., and, Addicks K., (2011) Differential patterns of spinal cord pathology induced by MP4, MOG peptide 35-55, and PLP peptide 178-191 in C57BL/6 mice. APMIS 119, 336-346.
36. Kurnellas M. P., Li H., Jain M. R., Giraud S. N., Nicot A. B., Ratnayake A., Heary R. F., and, Elkabes S., (2010) Reduced expression of plasma membrane calcium ATPase 2 and collapsin response mediator protein 1 promotes death of spinal cord neurons. Cell Death Differ. 17, 1501-1510.
37. Li C., Trapp B., Ludwin S., Peterson A., and, Roder J., (1998) Myelin associated glycoprotein modulates glia-axon contact in vivo. J. Neurosci. Res. 51, 210-217.
38. Mangas A., Vecino E., David R. F., Geffard M., and, Covenas R., (2013) GEMSP exerts a myelin-protecting role in the rat optic nerve. Neurol. Res. 35, 903-911.
39. Marcus J., Honigbaum S., Shroff S., Honke K., Rosenbluth J., and, Dupree J. L., (2006) Sulfatide is essential for the maintenance of CNS myelin and axon structure. Glia 53, 372-381.
40. Mason J. L., Langaman C., Morell P., Suzuki K., and, Matsushima G. K., (2001) Episodic demyelination and subsequent remyelination within the murine central nervous system: changes in axonal calibre. Neuropathol. Appl. Neurobiol. 27, 50-58.
41. Mony J. T., Khorooshi R., and, Owens T., (2014) Chemokine receptor expression by inflammatory T cells in EAE. Front. Cell. Neurosci. 8, 187.
42. Nada S. E., Tulsulkar J., Raghavan A., Hensley K., and, Shah Z. A., (2012) A derivative of the CRMP2 binding compound lanthionine ketimine provides neuroprotection in a mouse model of cerebral ischemia. Neurochem. Int. 61, 1357-1363.
43. Ohno N., Chiang H., Mahad D. J., Kidd G. J., Liu L., Ransohoff R. M., Sheng Z. H., Komuro H., and, Trapp B. D., (2014) Mitochondrial immobilization mediated by syntaphilin facilitates survival of demyelinated axons. Proc. Natl Acad. Sci. USA 111, 9953-9958.
44. Peters A., Moss M. B., and, Sethares C., (2000) Effects of aging on myelinated nerve fibers in monkey primary visual cortex. J. Comp. Neurol. 419, 364-376.
45. Petratos S., Li Q. X., George A. J., Hou X., Kerr M. L., Unabia S. E., Hatzinisiriou I., Maksel D., Aguilar M. I., and, Small D. H., (2008) The beta-amyloid protein of Alzheimer's disease increases neuronal CRMP-2 phosphorylation by a Rho-GTP mechanism. Brain 131, 90-108.
46. Petratos S., Azari M. F., Ozturk E., Papadopoulos R., and, Bernard C. C., (2010) Novel therapeutic targets for axonal degeneration in multiple sclerosis. J. Neuropathol. Exp. Neurol. 69, 323-334.
47. Petratos S., Ozturk E., Azari M. F., et al,. (2012) Limiting multiple sclerosis related axonopathy by blocking Nogo receptor and CRMP-2 phosphorylation. Brain 135, 1794-1818.
48. Piaton G., Aigrot M. S., Williams A., et al,. (2011) Class 3 semaphorins influence oligodendrocyte precursor recruitment and remyelination in adult central nervous system. Brain 134, 1156-1167.
49. Pierson E., Simmons S. B., Castelli L., and, Goverman J. M., (2012) Mechanisms regulating regional localization of inflammation during CNS autoimmunity. Immunol. Rev. 248, 205-215.
50. Quattrone A., Gambardella A., Bono F., et al,. (1996) Autosomal recessive hereditary motor and sensory neuropathy with focally folded myelin sheaths: clinical, electrophysiologic, and genetic aspects of a large family. Neurology 46, 1318-1324.
51. Rebai T., Mhiri C., Heine P., Charfi H., Meyrignac C., and, Gherardi R., (1989) Focal myelin thickenings in a peripheral neuropathy associated with IgM monoclonal gammopathy. Acta Neuropathol. 79, 226-232.
52. Recks M. S., Addicks K., and, Kuerten S., (2011) Spinal cord histopathology of MOG peptide 35-55-induced experimental autoimmune encephalomyelitis is time- and score-dependent. Neurosci. Lett. 494, 227-231.
53. Recks M. S., Stormanns E. R., Bader J., Arnhold S., Addicks K., and, Kuerten S., (2013) Early axonal damage and progressive myelin pathology define the kinetics of CNS histopathology in a mouse model of multiple sclerosis. Clin. Immunol. 149, 32-45.
54. Ricard D., Stankoff B., Bagnard D., et al,. (2000) Differential expression of collapsin response mediator proteins (CRMP/ULIP) in subsets of oligodendrocytes in the postnatal rodent brain. Mol. Cell Neurosci. 16, 324-337.
55. Ricci G., Vesci L., Nardini M., Arduini A., Storto S., Rosato N., and, Cavallini D., (1989) Detection of 2H-1,4-thiazine-5,6-dihydro-3,5-dicarboxylic acid (lanthionine ketimine) in the bovine brain by a fluorometric assay. Biochim. Biophys. Acta 990, 211-215.
56. Rogemond V., Auger C., Giraudon P., Becchi M., Auvergnon N., Belin M. F., Honnorat J., and, Moradi-Ameli M., (2008) Processing and nuclear localization of CRMP2 during brain development induce neurite outgrowth inhibition. J. Biol. Chem. 283, 14751-14761.
57. Rosenbluth J., (1966) Redundant myelin sheaths and other ultrastructural features of the toad cerebellum. J. Cell Biol. 28, 73-93.
58. Rosenbluth J., Stoffel W., and, Schiff R., (1996) Myelin structure in proteolipid protein (PLP)-null mouse spinal cord. J. Comp. Neurol. 371, 336-344.
59. Schneider C. A., Rasband W. S., and, Eliceiri K. W., (2012) NIH Image to ImageJ: 25 years of image analysis. Nat. Met. 9, 671-675.
60. Seiwa C., Sugiyama I., Yagi T., Iguchi T., and, Asou H., (2000) Fyn tyrosine kinase participates in the compact myelin sheath formation in the central nervous system. Neurosci. Res. 37, 21-31.
61. Soutar M. P., Thornhill P., Cole A. R., and, Sutherland C., (2009) Increased CRMP2 phosphorylation is observed in Alzheimer's disease; does this tell us anything about disease development? Curr. Alzheimer Res. 6, 269-278.
62. Sturrock R. R., (1976) Changes in neurologia and myelination in the white matter of aging mice. J. Gerontol. 31, 513-522.
63. Sun Y., Fei T., Yang T., Zhang F., Chen Y. G., Li H., and, Xu Z., (2010) The suppression of CRMP2 expression by bone morphogenetic protein (BMP)-SMAD gradient signaling controls multiple stages of neuronal development. J. Biol. Chem. 285, 39039-39050.
64. Suzuki Y., Nakagomi S., Namikawa K., Kiryu-Seo S., Inagaki N., Kaibuchi K., Aizawa H., Kikuchi K., and, Kiyama H., (2003) Collapsin response mediator protein-2 accelerates axon regeneration of nerve-injured motor neurons of rat. J. Neurochem. 86, 1042-1050.
65. Varrin-Doyer M., Vincent P., Cavagna S., Auvergnon N., Noraz N., Rogemond V., Honnorat J., Moradi-Ameli M., and, Giraudon P., (2009) Phosphorylation of collapsin response mediator protein 2 on Tyr-479 regulates CXCL12-induced T lymphocyte migration. J. Biol. Chem. 284, 13265-13276.
66. Varrin-Doyer M., Nicolle A., Marignier R., Cavagna S., Benetollo C., Wattel E., and, Giraudon P., (2012) Human T lymphotropic virus type 1 increases T lymphocyte migration by recruiting the cytoskeleton organizer CRMP2. J. Immunol. 188, 1222-1233.
67. Vincent P., Collette Y., Marignier R., et al,. (2005) A role for the neuronal protein collapsin response mediator protein 2 in T lymphocyte polarization and migration. J. Immunol. 175, 7650-7660.
68. Vuaillat C., Varrin-Doyer M., Bernard A., Sagardoy I., Cavagna S., Chounlamountri I., Lafon M., and, Giraudon P., (2008) High CRMP2 expression in peripheral T lymphocytes is associated with recruitment to the brain during virus-induced neuroinflammation. J. Neuroimmunol. 193, 38-51.
69. Wilson S. M., Moutal A., Melemedjian O. K., Wang Y., Ju W., Francois-Moutal L., Khanna M., and, Khanna R., (2014) The functionalized amino acid (S)-Lacosamide subverts CRMP2-mediated tubulin polymerization to prevent constitutive and activity-dependent increase in neurite outgrowth. Front. Cell. Neurosci. 8, 196.